Metered-dose inhaler

Revision as of 17:36, 18 May 2009 by Brian Blank (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Metered-dose inhaler

Articles

Most recent articles on Metered-dose inhaler

Most cited articles on Metered-dose inhaler

Review articles on Metered-dose inhaler

Articles on Metered-dose inhaler in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Metered-dose inhaler

Images of Metered-dose inhaler

Photos of Metered-dose inhaler

Podcasts & MP3s on Metered-dose inhaler

Videos on Metered-dose inhaler

Evidence Based Medicine

Cochrane Collaboration on Metered-dose inhaler

Bandolier on Metered-dose inhaler

TRIP on Metered-dose inhaler

Clinical Trials

Ongoing Trials on Metered-dose inhaler at Clinical Trials.gov

Trial results on Metered-dose inhaler

Clinical Trials on Metered-dose inhaler at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Metered-dose inhaler

NICE Guidance on Metered-dose inhaler

NHS PRODIGY Guidance

FDA on Metered-dose inhaler

CDC on Metered-dose inhaler

Books

Books on Metered-dose inhaler

News

Metered-dose inhaler in the news

Be alerted to news on Metered-dose inhaler

News trends on Metered-dose inhaler

Commentary

Blogs on Metered-dose inhaler

Definitions

Definitions of Metered-dose inhaler

Patient Resources / Community

Patient resources on Metered-dose inhaler

Discussion groups on Metered-dose inhaler

Patient Handouts on Metered-dose inhaler

Directions to Hospitals Treating Metered-dose inhaler

Risk calculators and risk factors for Metered-dose inhaler

Healthcare Provider Resources

Symptoms of Metered-dose inhaler

Causes & Risk Factors for Metered-dose inhaler

Diagnostic studies for Metered-dose inhaler

Treatment of Metered-dose inhaler

Continuing Medical Education (CME)

CME Programs on Metered-dose inhaler

International

Metered-dose inhaler en Espanol

Metered-dose inhaler en Francais

Business

Metered-dose inhaler in the Marketplace

Patents on Metered-dose inhaler

Experimental / Informatics

List of terms related to Metered-dose inhaler

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

ProAir-HFA
Albuterol Sulfate(US)

A metered-dose inhaler (MDI) is a device that helps deliver a specific amount of medication to the lungs. It is commonly used to treat asthma, chronic obstructive pulmonary disease (COPD), and other respiratory problems. Because of normal naming conventions, MDIs are considered aerosolized.

An inhaler consists of 2 major components. The canister and a mouthpiece. The canister itself consists a metering dose valve with an actuating stem, with the inside containing the aerosol propellant and medication. The mouthpiece contains the mating discharge nozzle and generally includes a dust cap to prevent contamination.

Once assembled the patient then uses the inhaler by pressing down on the top of the canister, with their thumb supporting lower portion of the mouthpiece, thus releases a mist of medicine that is then breathed into the lungs.

The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of those two. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as (cromoglicate or nedocromil).

Benefits of MDIs

Through inhalation, it takes only five to 15 minutes for short-acting bronchodilators (quick-relief medicine) to have an effect, compared to oral asthma medicines, which can take one to three hours. With an inhaler, there are also fewer medication side effects, because the medicine goes right to the lungs and not to other parts of the body. A holding chamber (or spacer device) attached to the inhaler can help make taking the medication easier, for adults and children. However, MDIs approved for pediatric use in the US are changing constantly. FDA

Spacers

Spacers are tubes attached to the inhaler that act as a reservoir or holding chamber. They serve to hold the medication that is sprayed by the inhaler. This makes it easier to use the inhaler and helps ensure that more of the medication gets into the lungs instead of just into the mouth or the air. With proper use, a spacer can make an inhaler 20 percent more effective in delivering medicine. Spacers can be especially helpful to adults and children who find a regular inhaler hard to use. People who use corticosteroid inhalers should use a spacer to prevent getting the medicine in their mouth, where oral yeast infections can occur.

When does an inhaler need to be replaced?

A metered dose inhaler contains enough medication for a certain number of puffs which is printed on the canister. Even though the inhaler may continue to work beyond that number of uses, the amount of medication delivered may not be correct. It is important to keep track of the number of times an inhaler was used, so that it can be replaced after its recommended number of uses. The manufacturer of Ventolin has addressed this issue by adding in a counter to the mouthpiece, as has the manufacturer of Advair. Also, depending on the manufacturer, inhalers are sold as a complete unit or the individual canister as a refill prescription.

Discontinuation of CFC Inhalers

In the US, Up until December, 2008, inhalers may have contained chlorofluorocarbons as a form of propellant to deliver the medication. Under the 1987 Montreal Protocol on Substances that Deplete the Ozone Layer, all inhalers that contain CFCs are being discontinued for hydro-fluoroalkane-pressurized metered dose inhalers (HFA pMDIs).

See also

Template:SIB

Template:WH Template:WikiDoc Sources